Enhanced malignant tumorigenesis in Cdk4 transgenic mice

Oncogene

Volumn 23, Issue 10, 2004, Pages 1863-1873

  Miliani De Marval, Paula L ^a   Macias, Everardo ^a   Conti, Claudio J ^b   Rodriguez Puebla, Marcelo L ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Carcinogenesis; CDK4; Cell cycle; Cyclin; Papillomas; Skin

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P21; PROTEIN P27; RAS PROTEIN; TUMOR PROMOTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENICITY; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; EPIDERMIS HYPERPLASIA; EPITHELIUM DYSPLASIA; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PAPILLOMA; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SKIN CARCINOGENESIS; SKIN FIBROSIS; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; HUMANS; MICE; MICE, TRANSGENIC; PAPILLOMA; PROTO-ONCOGENE PROTEINS; SKIN NEOPLASMS;

ANIMALIA; MUS MUSCULUS;

EID: 1842429910     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207309     Document Type: Article

References (61)

1. Aldaz M and Conti C. (1989). Experimental and Clinical Aspects. Conti C, Slaga T and Klein-Szanto A (eds). Raven Press: New York.
2. An H, Beckmann MW, Reifenger G, Bender HG and Niederacher D. (1999). Am. J. Pathol., 154, 113-118.
3. Berenblum I. (1954). Adv. Cancer Res., 2, 129-175.
4. Bianchi A, Aldaz MC and Conti CJ. (1990). Proc. Natl. Acad. Sci. USA, 87, 6902-6906.
5. Bianchi AB, Fischer SM, Robles AI, Rinchik EM and Conti CJ. (1993). Oncogene, 8, 1127-1133.
6. Boutwell RK. (1964). Prog. Exp. Tumor Res., 4, 207-250.
7. Conti C. (1992). Cancer Bull., 54, 62-128.
8. Dei Tos A, Doglioni C, Piccini S, Sciot R, Furlanetto A, Boiocchi M, Dal Cin P, Maestro R, Fletcher C and Tallini G. (2000). J. Pathol., 190, 531-536.
9. DiGiovanni J. (1992). Pharmacol. Theor., 54, 62-128.
10. He J, Allen JR, Collins VP, Allalunis-Turner MJ, Godbout R, Day RS and James CD. (1994). Cancer Res., 54, 5804-5807.
11. He J, Olson J and James C. (1995). Cancer Res., 55, 4833-4836.
12. Holland EC, Hively WP, Gallo V and Varmus HE. (1998). Genes Dev., 12, 3644-3649.
13. Hunter T and Pines J. (1994). Cell, 79, 573-582.
14. Jacks T and Weinberg R. (1998). Science, 280, 1035-1036.
15. Kanoe H, Nakayama T, Murakami H, Hosaka T, Yamamoto H, Nakashima Y, Tsuboyama T, Nakamura T, Sasaki M and Toguchida J. (1998). Anticancer Res., 18, 2317-2321.
16. Lam P, Di Tomaso E, Ng H, Pang J, Roussel M and Hjelm N. (2000). Br. J. Neurosurg., 14, 28-32.
17. Lazarov M, Kubo Y, Cai T, Dajee M, Tarutani M, Lin Q, Fang M, Tao S, FGreen C and Kharavi P. (2002). Nat. Med., 8, 1105-1114.
18. Malumbres M, Ortega S and Barbacid M. (2000). Biol. Chem., 38, 827-838.
19. McConnell B, Gregory F, Stott F, Hara E and Peters G. (1999). Mol. Cell. Biol., 19, 1981-1989.
20. Miliani de Marval P, Gimenez-Conti I, LaCava M, Martinez L, Conti C and Rodriguez-Puebla M. (2001). Am. J. Pathol., 159, 369-379.
21. Morris M, Hepburn P and Wynford-Thomas D. (2002). Oncogene, 21, 4277-4288.
22. Motokura T and Arnold A. (1993). Biochim. Biophys. Acta, 1155, 63-78.
23. Nevins J, Chellappan S, Mudryj M, Hiebert S, Devoto S, Horowitz J, Hunter T and Pines J. (1991). Cold Spring Harb. Symp. Quant. Biol., 56, 157-162.
24. Nevins JR. (1992). Science, 258, 424-429.
25. Nikitakis N, Drachenberg C and Papadimitriou J. (2002). Exp. Mol. Pathol., 73, 198-208.
26. Ohta M, Nagai H, Shimizu M, Rasio D, Berd D, Mastrangelo M, Singh AD, Shields JA, Shields CJ and Croce CM. (1994). Cancer Res., 54, 5269-5272.
27. Parry D, Mahony D, Wills K and Lees E. (1999). Mol. Cell. Biol., 19, 1775-1783.
28. Pierce AM, Gimenez-Conti IB, Schneider-Broussard R, Martinez LA, Conti CJ and Johnson DG. (1998). Proc. Natl. Acad. Sci. USA, 95, 8858-8863.
29. Pines J. (1995). Semin. Cancer Biol., 6, 63-72.
30. Ramirez R, Herbert B, Vaughan M, Zou Y, Gandia K, Morales C, Wright W and Shay J. (2003). Oncogene, 22, 433-444.
31. Rane SG, Cosenza S, Mettus RV and Reddy EP. (2002). Mol. Cell. Biol., 22, 644-656.
32. Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Premkumar Reddy E and Barbacid M. (1999) 22, 44-52.
33. Robles A, Rodriguez-Puebla M, Glick A, Trempus C, Hansen L, Sicinski P, Tennant R, Weinberg R, Yuspa S and Conti C. (1998). Genes Dev., 12, 2469-2474.
34. Robles AI and Conti CJ. (1995). Carcinogenesis, 16, 781-786.
35. Robles AI, Larcher F, Whalin RB, Murillas R, Richie E, Gimenez-Conti IB, Jorcano JL and Conti CJ. (1996). Proc. Natl. Acad. Sci. USA, 93, 7634-7638.
36. Rodriguez-Puebla ML, LaCava M, Bolontrade M, Rusell J and Conti C. (1999a). Mol. Carcinog., 26, 150-156.
37. Rodriguez-Puebla ML, LaCava M and Conti C. (1999b). Cell growth Diff., 10, 467-472.
38. Rodriguez-Puebla ML, LaCava M, Gimenez-Conti IB, Jonhson DG and Conti CJ. (1998). Oncogene, 17, 2251-2258.
39. Rodriguez-Puebla ML, Miliani de Marval PL, LaCava M, Moons DS, Kiyokawa H and Conti CJ. (2002). Am. J. Pathol., 161, 405-411.
40. Rodriguez-Puebla ML, Robles AI and Conti CJ. (1999c). Mol. Carcinogen., 24, 1-6.
41. Roussel MF. (1999). Oncogene, 18, 5311-5317.
42. Schmit E, Ichimura K and Reifenberger G. (1994). Cancer Res., 54, 6321-6324.
43. Sherr CJ. (1995a). Proc. Assoc. Am. Physicians, 107, 181-186.
44. Sherr CJ. (1994). Cell, 79, 551-555.
45. Sherr CJ. (1995b). Trends Biochem. Sci., 20, 187-190.
46. Sherr CJ. (1996). Science, 274, 1672-1677.
47. Sherr CJ and Roberts JM. (1995). Genes Dev., 9, 1149-1163.
48. Slaga TJ. (1989). Carcinogenesis. A Comprehesive Survey, Vol 11. Conti CJ, Slaga TJ and Klein-Szanto AJ (eds). Raven Press: New York, pp. 1-18.
49. Sonoda Y, Yoshimoto T and Sekiya T. (1995). Oncogene, 11, 2145-2149.
50. Sotillo R, Dubus P, Martin J, de la Cueva E, Ortega S, Malumbres M and Barbacid M. (2001a). EMBO J., 20, 6637-6647.
51. Sotillo R, Garcia J, Ortega S, Martin J, Dubus P, Barbacid M and Malumbres M. (2001b). Proc. Natl. Acad. Sci. USA, 98, 13312-13317.
52. Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, Stoppa-Luonnet D, Bernard J and Bressac-de Paillerets R. (1998). Hum. Mol. Genet., 7, 209-216.
53. Tofgard R, Roop D and Yuspa S. (1985). Carcinogenesis, 6, 655-657.
54. Tsutsui T, Hesabi B, Moons DS, Pandolfi P, Hansel K, Koff A and Kiyokawa H. (1999). Mol. Cell. Biol., 19, 7011-7019.
55. Weinberg R. (1996). Cytokines Mol. Ther., 2, 105-110.
56. Wölfel T, Hauer M, Schneider J, Serrano M, Wölfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Büschenfelde KH and Beach D. (1995). Science, 269, 1281-1284.
57. Xiong Y. (1996). Biochim. Biophys. Acta, 1288, 1-5.
58. Yuspa S, Hennings H, Roop D, Strickland J and Greenhalgh D. (1990). Environ. Health Perspect., 88, 193-195.
59. Zhang J-M, Wei Q, Zhao X and Paterson B. (1999). EMBO J., 18, 926-933.
60. Zou X, Ray D, Aziyu A, Christov K, Boiko A, Gudko A and Kiyokawa H. (2002). Genes Dev., 16, 2923-2934.
61. Zuo L. (1996). Nat. Genet., 12, 97-99.